# Carbidopa and levodopa

NDC: 42291-467
Generic name: Carbidopa and levodopa
Labeler / Manufacturer: AvKARE
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20210406
Marketing ended: 20260531
FDA application: ANDA074260

## Active ingredients

- CARBIDOPA: 25 mg/1
- LEVODOPA: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42291-467"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42291-467
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bf52f4bc-a435-4938-e053-2995a90a6774